Clicky

Vaxart, Inc.(VXRT) News

Date Title
Oct 9 Vaxart Inc (VXRT) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Advances
Sep 30 Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
Aug 28 Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical Dysplasia
Aug 15 Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside
Aug 11 Vaxart Second Quarter 2024 Earnings: Misses Expectations
Jun 22 While institutions invested in Vaxart, Inc. (NASDAQ:VXRT) benefited from last week's 23% gain, retail investors stood to gain the most
Jun 14 Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
Jun 13 Vaxart Announces $40 Million Underwritten Offering of Common Stock
Jun 13 Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
May 14 Q1 2024 Vaxart Inc Earnings Call
May 14 Vaxart Inc (VXRT) Q1 2024 Earnings Call Transcript Highlights: Promising Developments and ...
May 13 Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
May 7 Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13
Apr 30 Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
Apr 9 Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
Mar 27 Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
Mar 20 Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 17 Estimating The Intrinsic Value Of Vaxart, Inc. (NASDAQ:VXRT)
Mar 15 Vaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call Transcript
Mar 15 Q4 2023 Vaxart Inc Earnings Call